Last updated on November 2019

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease


Brief description of study

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Clinical Study Identifier: NCT03926130

Find a site near you

Start Over

Wasatch Family Practice

Layton, UT United States
1.91miles
  Connect »

Care Access Research - Salt Lake City

Ogden, UT United States
9.0miles
  Connect »